(Alpha), (omega) -dicarboximide derivatives usable as uroselective adrenoceptor (alpha) 1a receptor blockers, preparation process and pharmaceutical compositions containing them

摘要

"244, sym -DICARBOXIMIDE DERIVATIVES USED AS URO-SELECTIVE 244 ~ 1A ~ ADRENERGIC RECEPTOR BLOCKERS, PREPARATION PROCESS, AND PHARMACEUTICAL COMPOSITIONS". The present invention relates to novel 244, sym -dicarboximide derivatives which selectively inhibit binding to 244 ~ 1A-adrenergic receptor, a receptor that has been shown to be important in the treatment of benign hyperplasia of prostate. The compounds of the present invention are potentially useful in the treatment of benign prostate hyperplasia.